Literature DB >> 2227530

Role of oxidatively modified LDL in atherosclerosis.

U P Steinbrecher1, H F Zhang, M Lougheed.   

Abstract

Oxidative modification of LDL is accompanied by a number of compositional and structural changes, including increased electrophoretic mobility, increased density, fragmentation of apolipoprotein B, hydrolysis of phosphatidylcholine, derivatization of lysine amino groups, and generation of fluorescent adducts due to covalent binding of lipid oxidation products to apo B. In addition, oxidation of LDL has been shown to result in numerous changes in its biologic properties that could have pathogenetic importance, including accelerated uptake in macrophages, cytotoxicity, and chemotactic activity for monocytes. The present article summarizes very recent developments related to the mechanism of oxidation of LDL by cells, receptor-mediated uptake of oxidized LDL in macrophages, the mechanism of phosphatidylcholine hydrolysis during LDL oxidation, and other biologic actions of oxidized LDL including cytotoxicity, altered eicosanoid metabolism, and effects on the secretion of growth factors and chemotactic factors. In addition, this review will examine the evidence for the presence of oxidized LDL in vivo and the evidence that oxidized LDL plays a pathogenetic role in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227530     DOI: 10.1016/0891-5849(90)90119-4

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  76 in total

1.  Lysophosphatidylcholine is generated by spontaneous deacylation of oxidized phospholipids.

Authors:  Jaewoo Choi; Wujuan Zhang; Xiaodong Gu; Xi Chen; Li Hong; James M Laird; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2010-10-25       Impact factor: 3.739

2.  Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein.

Authors:  M Freeman; Y Ekkel; L Rohrer; M Penman; N J Freedman; G M Chisolm; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 3.  Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis.

Authors:  June Yun; Petra Rocic; Yuh Fen Pung; Souad Belmadani; Ana Catarina Ribeiro Carrao; Vahagn Ohanyan; William M Chilian
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

4.  Treatment of macrophages with oxidized low-density lipoprotein increases their intracellular glutathione content.

Authors:  V M Darley-Usmar; A Severn; V J O'Leary; M Rogers
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

5.  Immunological evidence for hypochlorite-modified proteins in human kidney.

Authors:  E Malle; C Woenckhaus; G Waeg; H Esterbauer; E F Gröne; H J Gröne
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

6.  Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells.

Authors:  Nobuo Watanabe; Jaroslaw W Zmijewski; Wakako Takabe; Makiko Umezu-Goto; Claire Le Goffe; Azusa Sekine; Aimee Landar; Akira Watanabe; Junken Aoki; Hiroyuki Arai; Tatsuhiko Kodama; Michael P Murphy; Raman Kalyanaraman; Victor M Darley-Usmar; Noriko Noguchi
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

7.  Comparative toxicity of oxidatively modified low-density lipoprotein and lysophosphatidylcholine in cultured vascular endothelial cells.

Authors:  M Naito; K Yamada; T Hayashi; K Asai; N Yoshimine; A Iguchi
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

8.  Oxidative stress in children on hemodialysis: value of autoantibodies against oxidized low-density lipoprotein.

Authors:  Nurcan Cengiz; Esra Baskin; Nurzen Sezgin; Pinar Agras; Mehmet Haberal
Journal:  Pediatr Nephrol       Date:  2008-10-29       Impact factor: 3.714

9.  Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits.

Authors:  J H Braesen; U Beisiegel; A Niendorf
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Prevention by alpha-tocopherol and rutin of glutathione and ATP depletion induced by oxidized LDL in cultured endothelial cells.

Authors:  A Schmitt; R Salvayre; J Delchambre; A Nègre-Salvayre
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.